Form 4 · MRK
Merck director Christine E. Seidman reports an award of about 56 phantom Stocks
Christine E. Seidman, a Merck director, filed a Form 4 on Oct 1, 2026 at 1:52 PM ET reporting transactions on Sep 30, 2026.
The filing reports about 56 phantom Stocks in a grant or award (code A).
Reporting person
- Christine E. Seidman, director (as filed: Seidman Christine E)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | A | Phantom Stock (derivative) | 56 | $145.31 | Acquired | 21,490 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Oct 1, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Merck company file → · More Merck filings
Disclosures
- Editor holdings in MRK
- The editor holds no position in Merck (MRK). As of Oct 25, 2026.
- Last updated
- Oct 25, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold MRK.